New device aims to suck out dangerous lung clots
NCT ID NCT05560763
First seen Sep 30, 2025
Summary
This study tested a device called the FlowTriever2 Catheter in 50 people with acute pulmonary embolism (blood clots in the lungs). The catheter is threaded through a blood vessel to mechanically break up and remove the clot. Researchers measured safety by tracking serious complications like major bleeding or death within 48 hours, and effectiveness by checking if blood pressure in the lungs improved after the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baptist Health
Louisville, Kentucky, 40207, United States
-
Carondelet St. Joseph's Hospital
Tucson, Arizona, 85711, United States
-
Memorial Health University Medical Center
Savannah, Georgia, 31404, United States
-
Oklahoma Heart Institute
Tulsa, Oklahoma, 74104, United States
-
University of Tennessee Medical Center
Knoxville, Tennessee, 37920, United States
-
Virtua Health
Camden, New Jersey, 08103, United States
-
Yale University
New Haven, Connecticut, 06511, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
FlowTriever2 Catheter (a device used to mechanically remove blood clots from the pulmonary arteries)
What this could lead to
If successful, this could provide a safe and effective way to quickly remove large blood clots from the lungs, potentially improving breathing and heart function in people with pulmonary embolism.
What could go wrong
This was a small, single-arm study with only 50 participants, so results may not apply to everyone. There are risks of bleeding, vessel injury, or worsening condition during the procedure.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.